Treatment of Senile Dementia

  • Richard M. Torack
Part of the Monographien aus dem Gesamtgebiete der Psychiatrie book series (PSYCHIATRIE, volume 20)


A most amazing aspect of therapeutic considerations of dementia is the similarity of experiences occurring 75 years ago to those of modern medicine. For example, the usefulness of general supportive care is evident in the observations of Clouston (1884):

Excitement and new things or ways or places or persons should be avoided. Old people take best with what they have been accustomed to.

The diet is also very important. I find the first food of life to be the best at the opposite end of life. There is nothing like milk, given warm and in small quantities at a time, and often. Fatten your patient and you will improve him in mind.


Serum Uric Acid Carotid Endarterectomy Hyperbaric Oxygen Ergot Alkaloid Senile Dementia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander, D.A. (1972): “Senile Dementia”: A changing perspective. Br. J. Psychiatry 121, 207–214PubMedCrossRefGoogle Scholar
  2. Arie, T. (1973): Dementia in the elderly; management. Br. Med. J. 4, 602–604PubMedCrossRefGoogle Scholar
  3. Asian, A. (1974): Theoretical and practical aspects of chemotherapeutic techniques in the retardation of the aging process. In: Theoretical Aspects of Aging. Rockstein, M. (ed.). New York: Academic Press, pp. 145–156Google Scholar
  4. Bender, A.D. (1965): A pharmacodynamic basis for changes in drug activity associated with aging in the adult. Exp. Gerontol. 1, 237–247CrossRefGoogle Scholar
  5. Bergmann, K. (1974): Assessment of therapy in psychogeriatric illness. Gerontol. Clin. 16, 54–63CrossRefGoogle Scholar
  6. Berkley, H.J. (1900): A Treatise on Mental Disease. Appleton, New YorkGoogle Scholar
  7. Boyle, E., Aparicio, A., Canosa, F., Owen, D., Dash, H.H. (1974): Hyperbaric oxygen and acetazolamide in the treatment of senile cognitive functions. Fifth Int. Hyperbaric Conf. 1, 432–438Google Scholar
  8. Braham, J. (1971): Jakob-Creutzfeldt disease: Treatment by Amantidine. Br. Med. J. 4, 212–213PubMedCrossRefGoogle Scholar
  9. Cameron, D.E. (1958): The use of nucleic acid in aged patients with memory impairment. Am. J. Psychiatry 114, 943PubMedGoogle Scholar
  10. Chesrow, E.J., Kaplitz, S.E., Breme, J.T., Musci, J., Sabatini, R. (1962): Use of new benzodiazepine derivative (Valium) in chronically ill and disturbed elderly patients. J. Am. Geriatr. Soc. 10, 667–670PubMedGoogle Scholar
  11. Clouston, T.S. (1884): Clinical Lectures on Mental Disease. Philadelphia: Leas and SonCrossRefGoogle Scholar
  12. Coblentz, J.M., Mattis, S., Zengesser, L.H., Kasoff, S.S., Wisnieswki, H.M., Katzman, R. (1973): Presenile dementia: Clinical aspects and evaluation of cerebral-spinal fluid dynamics. Arch. Neurol. 29, 299–308PubMedCrossRefGoogle Scholar
  13. Cohen, S., Ditman, K.S. (1974): Gerovital-H3 in the treatment of the depressed aging patient. Psychomatics 15, 15Google Scholar
  14. Edwards, A.E., Hart, G.M. (1974): Hyperbaric oxygenation and the cognitive functioning of the aged. J. Am. Geriatr. Soc. 22, 376–379PubMedGoogle Scholar
  15. Eisdorfer, C., Conner, J.F., Wilkie, F.L. (1968): The effect of magnesium pemoline on cognition and behavior. J. Gerontol. 23, 283–288PubMedGoogle Scholar
  16. Eist, H., Seal, U.S. (1965): The permeability of the blood-brain barrier (BBB) and blood cerebrospinal fluid barrier (BLB) to C1 tagged ribonucleic acid (RNA). Am. J. Psychiatry 122, 584–586PubMedGoogle Scholar
  17. Engell, H.C., Boysen, G., Ladegaard-Petersen, H.J., Henriksen, H. (1972): Cerebral blood flow before and after carotid endarterectomy. Vasc. Surg. 6, 14–19PubMedGoogle Scholar
  18. Fisher, C.M. (1951): Senile dementia — a new explanation of its causation. Can. Med. Assoc. J. 65, 1–7PubMedGoogle Scholar
  19. Geraud, J., Bess, A., Rascal, A., Delpla, M., Marc-Vergnes (1963): Measurement of cerebral blood flow using Krypton 85. Some physiopathological and clinical applications. Rev. Neurol. 108, 542–557Google Scholar
  20. Gerin, J. (1969): Symptomatic treatment of cerebrovascular insufficiency with Hydergine. Curr. Ther. Res. 11, 539–546PubMedGoogle Scholar
  21. Glasky, A.J., Simon, L.N. (1966): Magnesium pemoline: Enhancement of brain RNA polymerases. Science 151, 702–703PubMedCrossRefGoogle Scholar
  22. Goldberg, R.I., Shuman, F.I. (1966): Pentamethylene-tetrazol, vasodilator, vitamin therapy for mentally confused geriatric patients: Double blind study. J. Am. Geriatr. Soc. 12, 589–593Google Scholar
  23. Goldfarb, A.I., Hochstadt, N.J., Jacobson, J.H., Weinstein, E.A. (1972): Hyperbaric oxygen treatment of organic mental syndrome in aged persons. J. Gerontol. 27, 212–217PubMedGoogle Scholar
  24. Goldstein, S.E. (1974): The use of mesoridazine in geriatrics. Curr. Ther. Res. 16, 316–323PubMedGoogle Scholar
  25. Hader, M., Schulman, P.M., Madonick, M.J. (1966): Paranoid conditions of late life treated with Trifluoperazine. Dis. Nerv. Syste. 27, 460–462Google Scholar
  26. Hakim, S., Adams, R.D. (1965): The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. J. Neurol. Sci. 2, 307–327PubMedCrossRefGoogle Scholar
  27. Hamilton, L.D., Bennett, J.L. (1962): The use of Trifluoperazine in geriatric patients with chronic brain syndrome. J. Am. Geriatr. Soc. 10, 140–147PubMedGoogle Scholar
  28. Hollister, L.E. (1975): Drugs for mental disorders of old age. J. Am. Med. Assoc. 234, 195–198CrossRefGoogle Scholar
  29. Hyden, H. (1960): The neuron. In: The Cell: Biochemistry, Physiology, Morphology. Brachet, J., Mirsky, A.E. (eds.). New York: Academic PressGoogle Scholar
  30. Hyden, H., Egyhazi, E. (1962): Nuclear RNA changes of nerve cells during a learning experiment in rats. Proc. Natl. Acad. Sci. 48, 1366–1372PubMedCrossRefGoogle Scholar
  31. Jacobs, E.A., Winter, P.M., Alvis, H.J., Small, S.M. (1969): Hyperoxygenation effect on cognitive functioning in the aged. N. Engl. J. Med. 28, 753–757CrossRefGoogle Scholar
  32. Kral, V.A., Solyom, L., Enesco, H.E. (1967): Effect of short-term oral RNA therapy on the serum uric acid level and memory function in senile versus senescent subjects. J. Am. Geriatr. Soc. 15, 364–372.PubMedGoogle Scholar
  33. Kral, V.A., Cahn, C., Deutsch, M., Mueller, H., Solyom, L. (1962): Procaine (Novocain) treatment of patients with senile and arteriosclerotic brain disease. Can. Med. Assoc, J. 87, 1109–1113Google Scholar
  34. Lavin, P., Alexander, C.P. (1975): Dementia associated with Clonidine therapy. Br. Med. J. 1, 628PubMedCrossRefGoogle Scholar
  35. Libow, L.S. (1973): Pseudo-senility: Acute and reversible organic brain syndrome. J. Am. Geriatr. Soc. 21, 112–120PubMedGoogle Scholar
  36. Meier-Ruge, W., Enz, A., Gygax, P., Hunziker, O., Iwangoff, P., Reichlmeier, K. (1975): Experimental pathology in basic research of the aging brain. In: Aging, Volume 2. Gershon, S., Raskin, A. (eds.). New York: Raven Press, pp. 55–126Google Scholar
  37. Messert, B., Wannamaker, B.B. (1974): Reappraisal of the adult occult hydrocephalus syndrome. Neurology 24, 224–231PubMedGoogle Scholar
  38. Perry, P.M., Drinkwater, J.E., Taylor, G.W. (1975): Cerebral function before and after carotid endarterectomy. Br. Med. J. 4, 215–216PubMedCrossRefGoogle Scholar
  39. Prien, R.F., Haber, P.A., Coffey, E.M. (1975): The use of psychoactive drugs in elderly patients with psychiatric disorders: Survey conducted in twelve Veteran Administration hospitals. J. Am. Geriatr. Soc. 23, 104–112PubMedGoogle Scholar
  40. Prien, R.F. (1973): Chemotherapy in chronic organic brain syndrome — A review of the literature. Psychopharmacol. Bull. 9, 5–20PubMedGoogle Scholar
  41. Rada, R.T., Kellner, R. (1976): The effects of Thiothixene in geriatric patients with chronic brain syndrome. Psychopharmacol. Bull. 12, 30–32PubMedGoogle Scholar
  42. Ratcliffe, J., Rittman, A., Wolf, S., Verity, M.A. (1975): Creutzfeldt-Jakob disease with focal onset unsuccessfully treated with Amantidine. Bull. Los Angeles Neurol. Soc. 40, 18–20PubMedGoogle Scholar
  43. Rosen, H.J. (1975): Mental decline in the elderly: Pharmacotherapy (Ergot alkaloids versus Papaverine). J. Am. Geriatr. Soc. 23, 169–174PubMedGoogle Scholar
  44. Sakalis, G., Oh, D., Gershon, S., Shapsin, B. (1974): A trial of Gerovital-H3 in depression during senility. Curr. Ther. Res. 16, 59–63PubMedGoogle Scholar
  45. Salzman, C., Shader, R.I. (1974): Psychopharmacology in the aged. Research considerations in geriatric psychopharmacology. J. Geriatr. Psychoatry 7, 165–184Google Scholar
  46. Sanders, W.L., Dunn, T.L. (1973): Creutzfeldt-Jakob disease treated with Amantidine. J. Neurol. Neurosurg. Psychiatry 86, 581–584CrossRefGoogle Scholar
  47. Shildkraut, J.J. (1965): The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am. J. Psychiatry 122, 509–522Google Scholar
  48. Snyder, B.D. (1975): Physostigmine. Antidote for anticholinergic poisoning. Minn. Med. 58, 456–477PubMedGoogle Scholar
  49. Sohn, R.S., Siegel, B.A., Gado, M., Torack, R.M. (1973): Alzheimer’s disease with abnormal cerebrospinal fluid flow. Neurology 23, 1058–1065PubMedGoogle Scholar
  50. Stern, F.H. (1970): Management of chronic brain syndrome secondary to cerebral arteriosclerosis with special reference to papaverine hydrochloride. J. Am. Geriatr. Soc. 18, 507–512PubMedGoogle Scholar
  51. Sved, S. (1965): The metabolism of exogenous ribonucleic acid injected into mice. Can. J. Biochem. 43, 949–958PubMedCrossRefGoogle Scholar
  52. Thompson, L.W., Davis, G.C., Obrist, W.D., Heyman, A. (1976): Effects of hyperbaric oxygen on behavioral and psychological measures in elderly demented patients. J. Gerontol. 31, 23–28PubMedGoogle Scholar
  53. Thornton, W.E. (1976): Dementia induced by methyldopa with haloperidol. N. Engl. J. Med. 294, 1222PubMedCrossRefGoogle Scholar
  54. Triboletti, F., Ferri, H. (1969): Hydergine for treatment of symptoms of cerebrovascular insufficiency. Curr. Ther. Res. 11, 609–620PubMedGoogle Scholar
  55. Walsh, A.C., Walsh, B.H. (1972): Senile and presenile dementia: Further observations on the benefits of a dicumarol-psychotherapy regimen. J. Am. Geriatr. Soc. 20, 127–131PubMedGoogle Scholar
  56. Yau, T.M. (1974): Gerovital-H3, monoamine oxidases and brain monamines. In: Theory of Aging. Rockstein, M. (Ed.). New York: Academic Press, pp. 157–165Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1978

Authors and Affiliations

  • Richard M. Torack
    • 1
  1. 1.School of Medicine, Department of PathologyWashington UniversitySt. LouisUSA

Personalised recommendations